1-20 of 99
Arndt Hartmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PS16-01: Comparison of an Atezolizumab monotherapy window followed by Atezolizumab and chemotherapy vs. Atezolizumab and chemotherapy alone in triple negative breast cancer (TNBC) – final analysis of the neoadjuvant neoMono trial

Free
Hans-Christian Kolberg, Johannes Schumacher, Ramona Erber, Michael Braun, Peter A. Fasching, Eva-Maria Grischke, Christian Schem, Michael P. Lux, Mustafa Deryal, Oliver Hoffmann, Bernhard Heinrich, Georg Kunz, Kristina Lübbe, Petra Krabisch, Arndt Hartmann, Philip Raeth, Sabine Kasimir-Bauer, Cornelia Kolberg-Liedtke
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PS16-01.
https://doi.org/10.1158/1538-7445.SABCS23-PS16-01
Published: 02 May 2024
View articletitled, Abstract PS16-01: Comparison of an Atezolizumab monotherapy window followed by Atezolizumab and chemotherapy vs. Atezolizumab and chemotherapy alone in triple negative breast cancer (TNBC) – final analysis of the neoadjuvant neoMono trial
Journal Articles

Abstract 7570: Molecular subtyping and immunohistochemistry validation identifies muscle Invasive bladder cancer subgroups with poorer overall survival

Free
Jiarui Zhang, Mingxiao Feng, Neil Beeharry, Shibu Thomas, Ralph Wirtz, Arndt Hartmann, Markus Eckstein, Woonyoung Choi
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 7570.
https://doi.org/10.1158/1538-7445.AM2024-7570
Published: 22 March 2024
View articletitled, Abstract 7570: Molecular subtyping and immunohistochemistry validation identifies muscle Invasive bladder cancer subgroups with poorer overall survival
Journal Articles

Abstract 6172: Accurate PD-L1 IHC assessment in urothelial carcinoma by an AI algorithm robust across multiple sites, antibody clones, and scanners

Free
Niklas Abele, Diego Calvopiña, David Mulder, Patrick Frey, Emre Karakok, Fadime G. Salman, Murat Oktay, Markus Eckstein, Sebastian Springenberg, Arndt Hartmann, Tobias Lang
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6172.
https://doi.org/10.1158/1538-7445.AM2024-6172
Published: 22 March 2024
View articletitled, Abstract 6172: Accurate PD-L1 IHC assessment in urothelial carcinoma by an AI algorithm robust across multiple sites, antibody clones, and scanners
Journal Articles

Abstract 6075: Comprehensive genomic characterization of early-stage bladder cancer from 438 patients by whole genome- and exome sequencing

Free
Frederik Prip, Philippe Lamy, Iver Nordentoft, Sia Viborg Lindskrog, Trine Strandgaard, Karin Birkenkamp-Demtröder, Gregers G. Hermann, Astrid C. Petersen, Veronika Bahlinger, Marc-Oliver Grimm, Marcus Horstmann, Karin Mogensen, Roman Nawroth, Ulrika Segersten, Danijel Sikic, Kim E. M van Kessel, Tobias Maurer, Tatjana Simic, Arndt Hartmann, Ellen C. C. Zwarthoff, Per-Uno Malmström, Torben Steiniche, Jørgen Bjerggaard Jensen, Núria Malats, Francisco X. Real, Lars Dyrskjøt
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6075.
https://doi.org/10.1158/1538-7445.AM2023-6075
Published: 04 April 2023
View articletitled, Abstract 6075: Comprehensive genomic characterization of early-stage bladder cancer from 438 patients by whole genome- and exome sequencing
Journal Articles

Abstract PD11-03: PD11-03 Comparison of a mono Atezolizumab window followed by Atezolizumab and chemotherapy with Atezolizumab and chemotherapy in triple negative breast cancer – an interim analysis of the adaptive randomized neoadjuvant trial NeoMono

Free
Hans-Christian Kolberg, Johannes Schumacher, Ramona Erber, Michael Braun, Bernhard Heinrich, Oliver Hoffmann, Peter A. Fasching, Georg Kunz, Michael P. Lux, Christian Schem, Eva-Maria Grischke, Mustafa Deryal, Kristina Lübbe, Arndt Hartmann, Sabine Kasimir-Bauer, Cornelia Kolberg-Liedtke
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): PD11-03.
https://doi.org/10.1158/1538-7445.SABCS22-PD11-03
Published: 01 March 2023
View articletitled, Abstract PD11-03: PD11-03 Comparison of a mono Atezolizumab window followed by Atezolizumab and chemotherapy with Atezolizumab and chemotherapy in triple negative breast cancer – an interim analysis of the adaptive randomized neoadjuvant trial NeoMono
Journal Articles

Abstract OT2-29-01: neoMono - An adaptive randomized neoadjuvant two arm trial in patients with TNBC comparing a mono atezolizumab window followed by atezolizumab and chemotherapy with atezolizumab and chemotherapy

Free
Cornelia Kolberg-Liedtke, Johannes Schumacher, Ramona Erber, Michael Braun, Bernhard Heinrich, Oliver Hoffmann, Peter Fasching, Helmut Forstbauer, Anke Kleine-Tebbe, Georg Kunz, Michael Lux, Joachim Rom, Christian Schem, Nicole Stahl, Arndt Hartmann, Sabine Kasimir-Bauer, Hans-Christian Kolberg
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT2-29-01.
https://doi.org/10.1158/1538-7445.SABCS21-OT2-29-01
Published: 15 February 2022
View articletitled, Abstract OT2-29-01: neoMono - An adaptive randomized neoadjuvant two arm trial in patients with TNBC comparing a mono atezolizumab window followed by atezolizumab and chemotherapy with atezolizumab and chemotherapy
Journal Articles

Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling

Available to Purchase
Adrian Wullweber, Reiner Strick, Fabienne Lange, Danijel Sikic, Helge Taubert, Sven Wach, Bernd Wullich, Simone Bertz, Veronika Weyerer, Robert Stoehr, Johannes Breyer, Maximilian Burger, Arndt Hartmann, Pamela L. Strissel, Markus Eckstein
Journal: Cancer Research
Cancer Res (2021) 81 (6): 1552–1566.
https://doi.org/10.1158/0008-5472.CAN-20-2336
Published: 15 March 2021
View articletitled, Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling
Open the PDF for Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling in another window
Includes: Supplementary data
Journal Articles

Abstract 4327: Progranulin (GP88) is an independent prognostic factor for prostate cancer patients

Free
Helge W. Taubert, Amer Abdulrahman, Markus Eckstein, Rudolf Jung, Juan Guzman, Katrin Weigelt, Ginette Serrero, Binbin Yue, Carol Geppert, Robert Stöhr, Arndt Hartmann, Bernd Wullich, Sven Wach
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4327.
https://doi.org/10.1158/1538-7445.AM2020-4327
Published: 15 August 2020
View articletitled, Abstract 4327: Progranulin (GP88) is an independent prognostic factor for prostate cancer patients
Journal Articles

Abstract 3674: Protein levels of Piwi-like 1 and -2 protein are prognostic factors for muscle invasive urothelial bladder cancer patients

Free
Markus Eckstein, Rudolf Jung, Katrin Weigelt, Danijel Sikic, Robert Stöhr, Carol Geppert, Abbas Agaimy, Verena Lieb, Arndt Hartmann, Bernd Wullich, Sven Wach, Helge W. Taubert
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3674.
https://doi.org/10.1158/1538-7445.AM2019-3674
Published: 01 July 2019
View articletitled, Abstract 3674: Protein levels of Piwi-like 1 and -2 protein are prognostic factors for muscle invasive urothelial bladder cancer patients
Journal Articles

Abstract 3699: Tumor budding: A predictor for metastasis in the CAM xenograft model

Free
Julienne K. Muenzner, Raphela A. Ranjan, Markus Eckstein, Ramona Erber, Philipp Kunze, Carol I. Geppert, Matthias Ruebner, Tobias Baeuerle, Arndt Hartmann, Regine Schneider-Stock
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3699.
https://doi.org/10.1158/1538-7445.AM2019-3699
Published: 01 July 2019
View articletitled, Abstract 3699: Tumor budding: A predictor for metastasis in the CAM xenograft model
Journal Articles

Abstract 4037: Analytical and inter-observer comparability of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry assays in advanced clear cell renal cell carcinoma (CCRCC)

Free
Ulrich Sommer, Markus Eckstein, Johannes Ammann, Till Braunschweig, Stephan Macher-Goeppinger, Kristina Schwamborn, Stefanie Hieke-Schulz, Bernd Wullich, Manfred Wirth, Wilfried Roth, Ruth Knüchel, Wilko Weichert, Gustavo Baretton, Arndt Hartmann
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4037.
https://doi.org/10.1158/1538-7445.AM2019-4037
Published: 01 July 2019
View articletitled, Abstract 4037: Analytical and inter-observer comparability of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry assays in advanced clear cell renal cell carcinoma (CCRCC)
Journal Articles

Abstract 3485: Transcriptomic and metabolomic profiles in renal cell carcinoma (RCC) tumors reflect ontogeny of RCC subtypes

Free
Pascale Fisel, Florian Büttner, Anna Reustle, Verena Klumpp, Stefan Winter, Steffen Rausch, Jörg Hennenlotter, Stephan Kruck, Arnulf Stenzl, Judith Wahrheit, Denise Sonntag, Marcus Scharpf, Falko Fend, Abbas Agaimy, Arndt Hartmann, Jens Bedke, Matthias Schwab, Elke Schaeffeler
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3485.
https://doi.org/10.1158/1538-7445.AM2018-3485
Published: 01 July 2018
View articletitled, Abstract 3485: Transcriptomic and metabolomic profiles in renal cell carcinoma (RCC) tumors reflect ontogeny of RCC subtypes
Journal Articles

Abstract 3311: Loss of EZH2 at tumor invasive front is correlated with higher aggressiveness

Free
Julian Boehm, Julienne K. Muenzner, Aylin Caliskan, Benardina Ndreshkjana, Katharina Erlenbach-Wünsch, Susanne Merkel, Roland Croner, Tilman T. Rau, Carol I. Geppert, Arndt Hartmann, Adriana Vial-Roehe, Regine Schneider-Stock
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3311.
https://doi.org/10.1158/1538-7445.AM2018-3311
Published: 01 July 2018
View articletitled, Abstract 3311: Loss of EZH2 at tumor invasive front is correlated with higher aggressiveness
Journal Articles

Enhanced Acid Sphingomyelinase Activity Drives Immune Evasion and Tumor Growth in Non–Small Cell Lung Carcinoma

Free
Katerina Kachler, Maximilian Bailer, Lisanne Heim, Fabian Schumacher, Martin Reichel, Corinna D. Holzinger, Sonja Trump, Susanne Mittler, Juliana Monti, Denis I. Trufa, Ralf J. Rieker, Arndt Hartmann, Horia Sirbu, Burkhard Kleuser, Johannes Kornhuber, Susetta Finotto
Journal: Cancer Research
Cancer Res (2017) 77 (21): 5963–5976.
https://doi.org/10.1158/0008-5472.CAN-16-3313
Published: 31 October 2017
View articletitled, Enhanced Acid Sphingomyelinase Activity Drives Immune Evasion and Tumor Growth in Non–Small Cell Lung Carcinoma
Open the PDF for Enhanced Acid Sphingomyelinase Activity Drives Immune Evasion and Tumor Growth in Non–Small Cell Lung Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 3700: Association of the G/G-SNP309 variant in the mdm2 gene with earlier tumor onset in female renal cell carcinoma patients

Free
Christine G. Stoehr, Robert Stoehr, Antonia Wenners, Arndt Hartmann, Simone Bertz, Verena Spath, Bernhard Walter, Kerstin Junker, Holger Moch, Raoul Hintze, Stefan Denzinger, Elisabeth E. Bond, Gareth L. Bond, Karen Bluemke, Katrin Weigelt, Verena Lieb, Elke Nolte, Paolo Fornara, Bernd Wullich, Sven Wach, Helge W. Taubert
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3700.
https://doi.org/10.1158/1538-7445.AM2016-3700
Published: 15 July 2016
View articletitled, Abstract 3700: Association of the G/G-SNP309 variant in the mdm2 gene with earlier tumor onset in female renal cell carcinoma patients
Journal Articles

Abstract 2769: Response to 5FU therapy in colorectal cancer is affected by EZH2-mediated BclX splicing

Free
Natalya Benderska, Maria Gazouli, Gerasimos Aravantinos, Arndt Hartmann, Regine Schneider-Stock
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2769.
https://doi.org/10.1158/1538-7445.AM2016-2769
Published: 15 July 2016
View articletitled, Abstract 2769: Response to 5FU therapy in colorectal cancer is affected by EZH2-mediated BclX splicing
Journal Articles

Abstract 476: Differential prognostic value of MYC immunohistochemistry in papillary RCC subtypes

Free
Julia Bellut, Simone Bertz, Elke Nolte, Christine Stoehr, Iris Polifka, Edwin Herrmann, Rudolf Jung, Arndt Hartmann, Bernd Wullich, Helge Taubert, Sven Wach
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 476.
https://doi.org/10.1158/1538-7445.AM2016-476
Published: 15 July 2016
View articletitled, Abstract 476: Differential prognostic value of MYC immunohistochemistry in papillary RCC subtypes
Journal Articles

Abstract 4009: Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep-sequencing

Free
Elke Nolte, Martin Hart, Sven Wach, Jaroslaw Szczyrba, Helge Taubert, Tilman Rau, Arndt Hartmann, Friedrich A. Grässer, Bernd Wullich
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4009.
https://doi.org/10.1158/1538-7445.AM2015-4009
Published: 01 August 2015
View articletitled, Abstract 4009: Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep-sequencing
Journal Articles

Abstract 5156: Establishment of a FISH based analysis for individual risk assessment of ccRCC patients on tissue microarrays

Free
Julia Grimm, Arndt Hartmann, Christine Stoehr, Martin Janssen, Frank Kunath, Michael Stöckle, Kerstin Junker
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 5156.
https://doi.org/10.1158/1538-7445.AM2015-5156
Published: 01 August 2015
View articletitled, Abstract 5156: Establishment of a FISH based analysis for individual risk assessment of ccRCC patients on tissue microarrays
Journal Articles

Abstract 563: Evaluation of EGFR mutation analysis performed by Sanger sequencing versus real-time PCR (EGFR RGQ PCR Kit)

Free
Wolfgang Dietmaier, Irene Schardt, Petra Rümmele, Eva Geissinger, Arndt Hartmann, Robert Stöhr
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 563.
https://doi.org/10.1158/1538-7445.AM2015-563
Published: 01 August 2015
View articletitled, Abstract 563: Evaluation of EGFR mutation analysis performed by Sanger sequencing versus real-time PCR (EGFR RGQ PCR Kit)